Chris T. Bitterman - Mar 8, 2023 Form 3 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Vice Pres Sales & Marketing
Signature
Chris T. Bitterman by /s/ John M. Hamm as attorney-in-fact
Stock symbol
CPIX
Transactions as of
Mar 8, 2023
Transactions value $
$0
Form type
3
Date filed
3/20/2023, 05:19 PM
Next filing
Mar 27, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CPIX Common Stock 5.28K Mar 8, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CPIX Options (right to buy) Mar 8, 2023 Common Stock 2K $3.22 Direct
holding CPIX Options (right to buy) Mar 8, 2023 Common Stock 5K $2.59 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.